RE: Sluggish start..10 Oct 2025 10:56
Jatw, how could this share be risky when this unique test that saves health services, governments, insurance companies $100k a year per patient? There are 260 millions such patients worldwide inc 15 million in the US where Tempus has 200,000 doctors on their books. Add now the EU CE Mark for the EU market, and surely later India and China, Middle East, Africa, all easily done with click of the mouse using Tempus platform. The only reason this hasn’t multi bagged YET is the manipulation by the MMs in tandem with IIs getting in cheaply as we have seen over the last 3 weeks and who don’t seem to have stopped nibbling with UBS for the first time in a while increasing their holdings to 8% today from their usual 5%. The lenders today seems keen too to convert to shares, another vote of confidence, adding £4 million to the balance sheet which strengthens RENX hands when negotiating deals in their current talks with a Top 10 global pharma. I see no risk whatsoever as commercialisation of the test has started hence the placing to accelerate partnerships and sales. To give an analogy, we are at the stage where an oil exploration minnow strike huge amount oil and now has raised the fund to start building the infrastructure for oil production for sale. Would you then consider this oil co is risky? We we are beyond that and in much better position as we are selling the test as I wrote ie selling oil in this example.